Skip to main content
. 2010 Jun;2(6):211–230. doi: 10.1002/emmm.201000073

Figure 6. CXCL12 and CXCR4 levels are increased in the stroma of HER2-driven breast cancer.

Figure 6

  1. Sections and histological analysis of HER2 (a–c), BLC (d.f) and Lum-A (g–i) human breast tumours using CXCL12-specific antibody.
  2. Sections and histological analysis of HER2 (a–c), BLC (d.f) and Lum-A (g–i) human breast tumours using CXCL4-specific antibody. Scale bars = 40 µm.